From: Impact of adjuvant chemotherapy for gliomatosis cerebri
Variable | Chemotreatment group (n = 19) | Control group (n = 18) | P |
---|---|---|---|
Age | Â | Â | 0.579 |
   Median | 44.4 | 43.5 |  |
   range | 13-58 | 11-67 |  |
Gender | Â | Â | 0.638 |
   Male | 12 | 10 |  |
   Female | 7 | 8 |  |
KPS score | Â | Â | 0.713 |
   ≥ 70 | 16 | 15 |  |
   < 70 | 3 | 3 |  |
Grade | Â | Â | 0.420 |
   Low | 13 | 10 |  |
   High | 6 | 8 |  |
Mass formation | Â | Â | 0.738 |
   Dominant mass | 9 | 9 |  |
   Diffuse infiltration | 10 | 9 |  |
Brainstem involvement | Â | Â | 0.717 |
   Yes | 6 | 5 |  |
   No | 13 | 13 |  |
Hemisphere involvement | Â | Â | 0.654 |
   Unilateral | 11 | 11 |  |
   Bilateral | 8 | 7 |  |
Operation | Â | Â | 0.823 |
   Biopsy | 12 | 12 |  |
   Partial tumor removal | 7 | 6 |  |